The Motley Fool

Incyte Aktie (NASDAQ:INCY)

Incyte isn't the only drugmaker with a JAK inhibitor, but Jakafi's differentiation as a JAK1 and JAK2 inhibitor has helped the company stay on top of the treatment paradigm for myelofibrosis.

$75.97 $0.08 (0.1%) Donnerstag, 30. Juni 2022 um 22:00:00 Mitteleuropäische Sommerzeit

About

Last updated 30-06-2022, 10:00:00pm CEST
Aktueller Kurs $75.97
Veränderung $0.08 (0.1%)
Schlusskurs $75.97
Eröffnung $75.44
Geld $27.23
Brief $82.00
Tagesspanne $74.76 - $76.79
52-Wochen-Spanne $61.91 - $84.86
Volumen 1,729,971
Durchschn. Volumen 1,418,935
Marktkapitalisierung $16,827,735,685.00
EPS (roll. Hochrechn.) $4.23

Related Articles